TruBridge (NASDAQ:TBRG) Downgraded by Wall Street Zen to Buy

Key Points

• Wall Street Zen downgraded TruBridge (TBRG) from a "strong-buy" to a "buy," with other analysts mixed and a MarketBeat consensus rating of "Hold" and an average price target of $23.38.
• IKS Health agreed to acquire TruBridge for $26.25 per share in cash, providing a clear exit valuation, but multiple shareholder-law firms have opened investigations and prior accounting/reporting issues raise regulatory and deal-completion risk.
• 88.64% of TruBridge shares are institutionally held and the stock trades around $25.77, near the offer level, with a market cap of approximately $384M.

TruBridge (NASDAQ:TBRG - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report released on Saturday.

Several other equities analysts also recently commented on TBRG. Cantor Fitzgerald downgraded TruBridge from an "overweight" rating to a "neutral" rating and upped their price objective for the company from $25.00 to $26.25 in a research report on Thursday. Zacks Research upgraded TruBridge from a "hold" rating to a "strong-buy" rating in a research report on Monday, April 6th. Royal Bank Of Canada started coverage on TruBridge in a research report on Friday, January 9th. They set a "sector perform" rating and a $23.00 target price for the company. Weiss Ratings reiterated a "sell (e+)" rating on shares of TruBridge in a research report on Wednesday, January 28th. Finally, Stephens decreased their target price on TruBridge from $20.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 1st. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $23.38.

TruBridge Trading Up 0.0%

TBRG opened at $25.77 on Friday. The stock has a market cap of $384.15 million, a price-to-earnings ratio of 128.85 and a beta of 0.75. The stock's 50 day moving average price is $18.61 and its 200-day moving average price is $20.11. TruBridge has a one year low of $13.88 and a one year high of $26.74. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.79 and a current ratio of 1.81.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Bridgeway Capital Management LLC bought a new position in TruBridge in the fourth quarter worth approximately $247,000. AQR Capital Management LLC grew its stake in TruBridge by 11.0% in the fourth quarter. AQR Capital Management LLC now owns 68,767 shares of the company's stock worth $1,518,000 after purchasing an additional 6,799 shares in the last quarter. Nellore Capital Management LLC grew its stake in TruBridge by 22.5% in the fourth quarter. Nellore Capital Management LLC now owns 915,034 shares of the company's stock worth $20,195,000 after purchasing an additional 168,002 shares in the last quarter. Mangrove Partners IM LLC bought a new position in TruBridge in the fourth quarter worth approximately $313,000. Finally, Verition Fund Management LLC bought a new position in TruBridge in the fourth quarter worth approximately $258,000. Institutional investors own 88.64% of the company's stock.

TruBridge News Summary

Here are the key news stories impacting TruBridge this week:

• Positive Sentiment: IKS Health (Inventurus) announced a definitive agreement to acquire TruBridge for $26.25 per share in cash, which supports a takeover premium and provides a clear exit valuation for shareholders. IKS Health Announces Agreement to Acquire TruBridge
• Positive Sentiment: Market reaction to the acquisition news has shown strength in IKS/related names and lifted sentiment around the deal, supporting TruBridge’s share price as buyers move toward the cash consideration level. IKS Health shares surge on TruBridge acquisition announcement
• Neutral Sentiment: Trading was halted briefly for “news pending” around the deal announcement — a routine market response to material M&A news. (No link available)
• Neutral Sentiment: Reported short interest data shows no meaningful short position reported in late April, so short squeezes or aggressive short activity are not currently a driving factor.
• Negative Sentiment: Multiple investor-rights and plaintiff law firms (Kahn Swick & Foti, Ademi LLP, Halper Sadeh, Holzer & Holzer, Monteverde & Associates, and others) have opened investigations into whether the $26.25 price and the sale process are fair to public shareholders — this increases legal/regulatory risk and could complicate or delay the transaction. TruBridge Investor Alert: Kahn Swick & Foti Investigates Ademi LLP investigates TruBridge Halper Sadeh investigating TruBridge sale
• Negative Sentiment: Cantor Fitzgerald downgraded TruBridge, signaling analyst concern about deal terms, outlook, or execution risk — a factor that can weigh on sentiment and buying interest despite the announced offer. Cantor Fitzgerald downgrades TruBridge
• Negative Sentiment: Regulatory/financial-reporting concerns remain in the background: prior disclosures about delayed 10-K filings and identified errors in revenue recognition, stock‑based comp and capitalized software costs have already pressured the stock and add uncertainty around governance and deal review. Holzer & Holzer investigation of TruBridge

TruBridge Company Profile

TruBridge, Inc is a technology solutions provider specializing in digital transformation and managed services for enterprise clients. The company focuses on helping organizations modernize and optimize their IT environments by leveraging cloud technologies, collaboration platforms, and security solutions. TruBridge's core business activities include consulting, implementation, migration, training and ongoing support for Microsoft 365, Azure and related cloud services.

TruBridge offers a comprehensive suite of services designed to guide clients through every stage of their cloud adoption journey.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.